TABLE 3.
LncRNAs in secondary changes of myocardial infarction.
| LncRNA | Target | Function | References |
| lncCIRBIL | Bclaf1 | Reduced infarcted area after I/R and cardiac protection. | Zhang Y. et al., 2021 |
| HOTAIR | EZH2/miR-451/CAB39 | Regulates oxidative stress and cardiac myocardial apoptosis during I/R | Meng et al., 2020 |
| H19 | COL1A1 | Form H19-YB-1 complex to decrease COL1A1 expression and preventing ECM deposition and cardiac remodeling after MI. | Choong et al., 2019 |
| SAIL | SAFB | Regulating cardiac fibrosis by promoting SAFB bind to rpb1. | Luo et al., 2021 |
| Safe | Sfrp2 mRNA | Binding Sfrp2 mRNA 3′-UTR and inhibited TGF-β- induced fibrosis. | Hao et al., 2019 |
| Cfast | COTL1/TRAP1/TGF-β signaling pathway | Competitively inhibits the interaction between COTL1 and TRAP1, thereby enhancing fibrosis-related gene expression and myofibroblasts transdifferentiating into CFs. | Zhang F. et al., 2021 |
| lncRNA 554 | TGF-β1 signaling pathway | Regulate CFs migration and ECM expression following MI. | Luo et al., 2020 |
| Chast | Plekhm1 | Prevent cardiac remodeling and hypertrophy. | Viereck et al., 2016 |
| Wisper | TIAR | Reduce the development of myocardial fibrosis after MI and prevent adverse remodeling. | Micheletti et al., 2017 |